{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:36:47Z","timestamp":1773466607114,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30772824"],"award-info":[{"award-number":["30772824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30772824"],"award-info":[{"award-number":["30772824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Nonspecific Orbital Inflammation (NSOI) represents a persistent and idiopathic proliferative inflammatory disorder, characterized by polymorphous lymphoid infiltration within the orbit. The transcription factor Interferon Regulatory Factor 8 (IRF8), integral to the IRF protein family, was initially identified as a pivotal element for the commitment and differentiation of myeloid cell lineage. Serving as a central regulator of innate immune receptor signaling, IRF8 orchestrates a myriad of functions in hematopoietic cell development. However, the intricate mechanisms underlying IRF8 production remain to be elucidated, and its potential role as a biomarker for NSOI is yet to be resolved.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>IRF8 was extracted from the intersection analysis of common DEGs of GSE58331 and GSE105149 from the GEO and immune- related gene lists in the ImmPort database using The Lasso regression and SVM-RFE analysis. We performed GSEA and GSVA with gene sets coexpressed with IRF8, and observed that gene sets positively related to IRF8 were enriched in immune-related pathways. To further explore the correlation between IRF8 and immune-related biological process, the CIBERSORT algorithm and ESTIMATE method were employed to evaluate TME characteristics of each sample and confirmed that high IRF8 expression might give rise to high immune cell infiltration. Finally, the GSE58331 was utilized to confirm the levels of expression of IRF8.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 314 differentially expressed genes (DEGs), some DEGs were found to be significantly different. With LASSO and SVM-RFE algorithms, we obtained 15 hub genes. For biological function analysis in IRF8, leukocyte mediated immunity, leukocyte cell-cell adhesion, negative regulation of immune system process were emphasized. B cells naive, Macrophages M0, Macrophages M1, T cells CD4 memory activated, T cells CD4 memory resting, T cells CD4 naive, and T cells gamma delta were shown to be positively associated with IRF8. While, Mast cells resting, Monocytes, NK cells activated, Plasma cells, T cells CD8, and T cells regulatory (Tregs) were shown to be negatively linked with IRF8. The diagnostic ability of the IRF8 in differentiating NSOI exhibited a good value.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study discovered IRF8 that are linked to NSOI. IRF8 shed light on potential new biomarkers for NSOI and tracking its progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12348-024-00410-4","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T12:01:52Z","timestamp":1718884912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The roles of IRF8 in nonspecific orbital inflammation: an integrated analysis by bioinformatics and machine learning"],"prefix":"10.1186","volume":"14","author":[{"given":"Zixuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"issue":"1","key":"410_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12886-021-02008-z","volume":"21","author":"B Eshraghi","year":"2021","unstructured":"Eshraghi B, Dehghan A, Javadi N, Fazel M (2021) Nonspecific orbital inflammation and thyroid eye disease, a rare comorbidity: Report of two cases and review of literature. BMC Ophthalmol 21(1):251. https:\/\/doi.org\/10.1186\/s12886-021-02008-z","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"410_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1055\/s-0040-1722636","volume":"82","author":"JA Garrity","year":"2021","unstructured":"Garrity JA (2021) Not a Tumor-Nonspecific orbital inflammation. J Neurol Surg B Skull Base 82(1):96\u201399. https:\/\/doi.org\/10.1055\/s-0040-1722636","journal-title":"J Neurol Surg B Skull Base"},{"issue":"4","key":"410_CR3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s10792-017-0610-7","volume":"38","author":"PS Braich","year":"2018","unstructured":"Braich PS, Kuriakose RK, Khokhar NS, Donaldson JC, McCulley TJ (2018) Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor. Int Ophthalmol 38(4):1485\u20131495. https:\/\/doi.org\/10.1007\/s10792-017-0610-7","journal-title":"Int Ophthalmol"},{"issue":"11","key":"410_CR4","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/jamaophthalmol.2017.3458","volume":"135","author":"JT Rosenbaum","year":"2017","unstructured":"Rosenbaum JT, Choi D, Harrington CA, Wilson DJ, Grossniklaus HE, Sibley CH et al (2017) Gene expression profiling and heterogeneity of nonspecific orbital inflammation affecting the lacrimal gland. JAMA Ophthalmol 135(11):1156\u20131162. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.3458","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"410_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.joco.2019.03.004","volume":"31","author":"B Eshraghi","year":"2019","unstructured":"Eshraghi B, Sonbolestan SA, Abtahi MA, Mirmohammadsadeghi A (2019) Clinical characteristics, histopathology, and treatment outcomes in adult and pediatric patients with nonspecific orbital inflammation. J Curr Ophthalmol 31(3):327\u2013334. https:\/\/doi.org\/10.1016\/j.joco.2019.03.004","journal-title":"J Curr Ophthalmol"},{"issue":"1","key":"410_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jemermed.2018.04.001","volume":"55","author":"XC Zhang","year":"2018","unstructured":"Zhang XC, Statler B, Suner S, Lloyd M, Curley D, Migliori ME (2018) Man with a swollen eye: Nonspecific orbital inflammation in an adult in the emergency department. J Emerg Med 55(1):110\u2013113. https:\/\/doi.org\/10.1016\/j.jemermed.2018.04.001","journal-title":"J Emerg Med"},{"issue":"3","key":"410_CR7","first-page":"645672405","volume":"52","author":"KM Sharifzadeh","year":"2024","unstructured":"Sharifzadeh KM, Farsi M, Sharifi A, Sardarinia M, Zand A (2024) Central serous chorioretinopathy associated with nonspecific orbital inflammation: a case report. J Int Med Res 52(3):645672405","journal-title":"J Int Med Res"},{"key":"410_CR8","doi-asserted-by":"publisher","first-page":"1318316","DOI":"10.3389\/fimmu.2024.1318316","volume":"15","author":"Z Wu","year":"2024","unstructured":"Wu Z, Fang C, Hu Y, Peng X, Zhang Z, Yao X, Peng Q (2024) Bioinformatic validation and machine learning-based exploration of purine metabolism-related gene signatures in the context of immunotherapeutic strategies for nonspecific orbital inflammation. Front Immunol 15:1318316","journal-title":"Front Immunol"},{"issue":"3","key":"410_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaapos.2016.02.004","volume":"20","author":"AB Callahan","year":"2016","unstructured":"Callahan AB, Scofield SM, Gallin PF, Kazim M (2016) Retained strabismus suture material masquerading as nonspecific orbital inflammation. J AAPOS 20(3):280\u2013282","journal-title":"J AAPOS"},{"issue":"3","key":"410_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0161-6420(97)30301-7","volume":"104","author":"I Mombaerts","year":"1997","unstructured":"Mombaerts I, Koornneef L (1997) Current status in the treatment of orbital myositis. Ophthalmology 104(3):402\u2013408","journal-title":"Ophthalmology"},{"issue":"9","key":"410_CR11","first-page":"512","volume":"22","author":"JS Kennerdell","year":"1991","unstructured":"Kennerdell JS (1991) The management of sclerosing nonspecific orbital inflammation. Ophthalmic Surg 22(9):512\u2013518","journal-title":"Ophthalmic Surg"},{"issue":"6","key":"410_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.survophthal.2019.06.006","volume":"64","author":"I Mombaerts","year":"2019","unstructured":"Mombaerts I, Ramberg I, Coupland SE, Heegaard S (2019) Diagnosis of orbital mass lesions: clinical, radiological, and pathological recommendations. Surv Ophthalmol 64(6):741\u2013756","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"410_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1442-9071.2009.02188.x","volume":"37","author":"SF Osborne","year":"2009","unstructured":"Osborne SF, Sims JL, Rosser PM (2009) Short-term use of Infliximab in a case of recalcitrant idiopathic orbital inflammatory disease. Clin Exp Ophthalmol 37(9):897\u2013900. https:\/\/doi.org\/10.1111\/j.1442-9071.2009.02188.x. (PMID: 20092603)","journal-title":"Clin Exp Ophthalmol"},{"issue":"9","key":"410_CR14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1442-9071.2011.02561.x","volume":"39","author":"AK Patel","year":"2011","unstructured":"Patel AK, Hoch S, Shindler KS (2011) Mycophenolate mofetil treatment of steroid-resistant idiopathic sclerosing orbital inflammation. CLIN EXP OPHTHALMOL 39(9):912\u2013913","journal-title":"CLIN EXP OPHTHALMOL"},{"issue":"5","key":"410_CR15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.survophthal.2016.03.002","volume":"61","author":"I Mombaerts","year":"2016","unstructured":"Mombaerts I, Rose GE, Garrity JA (2016) Orbital inflammation: Biopsy first. Surv Ophthalmol 61(5):664\u2013669","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"410_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00415-015-7926-x","volume":"263","author":"F Montagnese","year":"2016","unstructured":"Montagnese F, Wenninger S, Schoser B (2016) \u201cOrbiting around\u201d the orbital myositis: clinical features, differential diagnosis and therapy. J Neurol 263(4):631\u2013640","journal-title":"J Neurol"},{"issue":"2","key":"410_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","volume":"53","author":"U Cytlak","year":"2020","unstructured":"Cytlak U, Resteu A, Pagan S, Green K, Milne P, Maisuria S, McDonald D, Hulme G, Filby A, Carpenter B et al (2020) Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans. Immunity 53(2):353\u2013370","journal-title":"Immunity"},{"issue":"1","key":"410_CR18","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1038\/s41467-022-32401-1","volume":"13","author":"WW Luo","year":"2022","unstructured":"Luo WW, Tong Z, Cao P, Wang FB, Liu Y, Zheng ZQ, Wang SY, Li S, Wang YY (2022) Transcription-independent regulation of STING activation and innate immune responses by IRF8 in monocytes. Nat Commun 13(1):4822","journal-title":"Nat Commun"},{"issue":"1","key":"410_CR19","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/s41467-022-29514-y","volume":"13","author":"T Zhou","year":"2022","unstructured":"Zhou T, Zhu X, Ye Z, Wang YF, Yao C, Xu N, Zhou M, Ma J, Qin Y, Shen Y et al (2022) Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery. Nat Commun 13(1):1855","journal-title":"Nat Commun"},{"issue":"9","key":"410_CR20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.it.2023.07.004","volume":"44","author":"KL Liang","year":"2023","unstructured":"Liang KL, Laurenti E, Taghon T (2023) Circulating IRF8-expressing CD123(+)CD127(+) lymphoid progenitors: key players in human hematopoiesis. Trends Immunol 44(9):678\u2013692","journal-title":"Trends Immunol"},{"issue":"2","key":"410_CR21","doi-asserted-by":"publisher","first-page":"e2201724","DOI":"10.1002\/advs.202201724","volume":"10","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Ji M, Xia Y, Han X, Li M, Li W, Sun T, Zhang J, Lu F, Sun Y et al (2023) Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T-Cell Acute Lymphoblastic Leukemia. Adv Sci (Weinh) 10(2):e2201724","journal-title":"Adv Sci (Weinh)"},{"key":"410_CR22","doi-asserted-by":"crossref","unstructured":"Moorman HR, Reategui Y, Poschel DB, Liu K: IRF8: Mechanism of Action and Health Implications. Cells-Basel. 2022, 11(17)","DOI":"10.3390\/cells11172630"},{"issue":"11","key":"410_CR23","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","volume":"55","author":"BG Nixon","year":"2022","unstructured":"Nixon BG, Kuo F, Ji L, Liu M, Capistrano K, Do M, Franklin RA, Wu X, Kansler ER, Srivastava RM et al (2022) Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. Immunity 55(11):2044\u20132058","journal-title":"Immunity"},{"issue":"17","key":"410_CR24","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1016\/j.molcel.2021.07.018","volume":"81","author":"Z Cao","year":"2021","unstructured":"Cao Z, Budinich KA, Huang H, Ren D, Lu B, Zhang Z, Chen Q, Zhou Y, Huang YH, Alikarami F et al (2021) ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency. Mol Cell 81(17):3604\u20133622","journal-title":"Mol Cell"},{"key":"410_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-3-030-59038-3_21","volume":"1296","author":"DH Jo","year":"2020","unstructured":"Jo DH, Kim JH, Kim JH (2020) Tumor environment of retinoblastoma, intraocular cancer. Adv Exp Med Biol 1296:349\u2013358. https:\/\/doi.org\/10.1007\/978-3-030-59038-3_21","journal-title":"Adv Exp Med Biol"},{"key":"410_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1200\/EDBK_237987","volume":"39","author":"M Datta","year":"2019","unstructured":"Datta M, Coussens LM, Nishikawa H, Hodi FS, Jain RK (2019) Reprogramming the tumor microenvironment to improve immunotherapy: emerging strategies and combination therapies. Am Soc Clin Oncol Educ Book 39:165\u2013174","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"410_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK (2018) Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol 15(5):325\u2013340","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"410_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","volume":"26","author":"RK Jain","year":"2014","unstructured":"Jain RK (2014) Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26(5):605\u2013622","journal-title":"Cancer Cell"},{"key":"410_CR29","doi-asserted-by":"publisher","unstructured":"Al-Ghazzawi, K., Baum, S. H., Pfortner, R., Philipp, S., Bechrakis, N., and Gortz, G., et al. (2022). Evaluation of orbital lymphoproliferative and inflammatory disorders by gene expression analysis. Int J Mol Sci. 23(15). https:\/\/doi.org\/10.3390\/ijms23158609","DOI":"10.3390\/ijms23158609"},{"issue":"6","key":"410_CR30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41433-022-02068-5","volume":"37","author":"T Ang","year":"2023","unstructured":"Ang T, Juniat V, Selva D (2023) Autoimmune markers in screening for orbital inflammatory disease. Eye (Lond) 37(6):1088\u20131093. https:\/\/doi.org\/10.1038\/s41433-022-02068-5","journal-title":"Eye (Lond)"},{"issue":"1","key":"410_CR31","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1038\/s41598-023-33277-x","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu Z, Liu P, Huang B, Deng S, Song Z, Huang X, Yang J, Cheng S (2023) A novel Alzheimer\u2019s disease prognostic signature: identification and analysis of glutamine metabolism genes in immunogenicity and immunotherapy efficacy. Sci Rep 13(1):6895","journal-title":"Sci Rep"},{"key":"410_CR32","doi-asserted-by":"publisher","first-page":"7588084","DOI":"10.1155\/2022\/7588084","volume":"2022","author":"H Liu","year":"2022","unstructured":"Liu H, Chen L, Lei X, Ren H, Li G, Deng Z (2022) Identification of hub genes associated with nonspecific orbital inflammation by weighted gene coexpression network analysis. Dis Markers 2022:7588084. https:\/\/doi.org\/10.1155\/2022\/7588084","journal-title":"Dis Markers"},{"key":"410_CR33","doi-asserted-by":"crossref","unstructured":"Li P, Yi N, Ding CS, et al. Research on classification diagnosis model of psoriasis based on deep residual network. Digit Chin Med. 2021;4(2):92\u2013101.","DOI":"10.1016\/j.dcmed.2021.06.003"},{"issue":"6","key":"410_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/01676830.2017.1337185","volume":"36","author":"P Nalcacioglu","year":"2017","unstructured":"Nalcacioglu P, Acaroglu G (2017) Unilateral optic perineuritis due to nonspecific orbital inflammation: a case report. Orbit 36(6):452\u2013455","journal-title":"Orbit"},{"issue":"2","key":"410_CR35","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/IOP.0000000000002441","volume":"40","author":"C Yang","year":"2024","unstructured":"Yang C, Cho RI (2024) Bilateral diffuse extraocular muscle enlargement in nonspecific orbital inflammation. Ophthal Plast Reconstr Surg 40(2):e69","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"1","key":"410_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0161-6420(95)31066-4","volume":"102","author":"C Atabay","year":"1995","unstructured":"Atabay C, Tyutyunikov A, Scalise D, Stolarski C, Hayes MB, Kennerdell JS, Wall J (1995) Serum antibodies reactive with eye muscle membrane antigens are detected in patients with nonspecific orbital inflammation. Ophthalmology 102(1):145\u2013153","journal-title":"Ophthalmology"},{"issue":"1","key":"410_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12864-023-09946-6","volume":"25","author":"Z Wu","year":"2024","unstructured":"Wu Z, Li N, Gao Y, Cao L, Yao X, Peng Q (2024) Glutamine metabolism-related genes and immunotherapy in nonspecific orbital inflammation were validated using bioinformatics and machine learning. BMC Genomics 25(1):71","journal-title":"BMC Genomics"},{"issue":"19","key":"410_CR38","doi-asserted-by":"publisher","first-page":"e2101031","DOI":"10.1002\/advs.202101031","volume":"8","author":"D Li","year":"2021","unstructured":"Li D, Zhang Y, Qiu Q, Wang J, Zhao X, Jiao B, Zhang X, Yu S, Xu P, Dan Y et al (2021) IRF8 Impacts Self-Renewal of Hematopoietic Stem Cells by Regulating TLR9 Signaling Pathway of Innate Immune Cells. Adv Sci (Weinh) 8(19):e2101031","journal-title":"Adv Sci (Weinh)"},{"issue":"6\u20137","key":"410_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00439-020-02154-2","volume":"139","author":"S Salem","year":"2020","unstructured":"Salem S, Salem D, Gros P (2020) Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases. Hum Genet 139(6\u20137):707\u2013721","journal-title":"Hum Genet"},{"issue":"4","key":"410_CR40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12185-015-1761-9","volume":"101","author":"T Tamura","year":"2015","unstructured":"Tamura T, Kurotaki D, Koizumi S (2015) Regulation of myelopoiesis by the transcription factor IRF8. Int J Hematol 101(4):342\u2013351","journal-title":"Int J Hematol"},{"issue":"6","key":"410_CR41","first-page":"306","volume":"18","author":"S Onuora","year":"2022","unstructured":"Onuora S (2022) SLE risk variant regulates IRF8 expression. Nat Rev Rheumatol 18(6):306","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"410_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1753425916683751","volume":"23","author":"Y Jia","year":"2017","unstructured":"Jia Y, Han S, Li J, Wang H, Liu J, Li N, Yang X, Shi J, Han J, Li Y et al (2017) IRF8 is the target of SIRT1 for the inflammation response in macrophages. Innate Immun 23(2):188\u2013195","journal-title":"Innate Immun"},{"issue":"10","key":"410_CR43","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/eji.202250037","volume":"52","author":"L Grzelak","year":"2022","unstructured":"Grzelak L, Roesch F, Vaysse A, Biton A, Legendre R, Porrot F, Commere PH, Planchais C, Mouquet H, Vignuzzi M et al (2022) IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies. Eur J Immunol 52(10):1648\u20131661","journal-title":"Eur J Immunol"},{"issue":"1","key":"410_CR44","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41467-017-01070-w","volume":"8","author":"E Humblin","year":"2017","unstructured":"Humblin E, Thibaudin M, Chalmin F, Derangere V, Limagne E, Richard C, Flavell RA, Chevrier S, Ladoire S, Berger H et al (2017) IRF8-dependent molecular complexes control the Th9 transcriptional program. Nat Commun 8(1):2085","journal-title":"Nat Commun"},{"issue":"6","key":"410_CR45","doi-asserted-by":"publisher","first-page":"152300","DOI":"10.1016\/j.imbio.2022.152300","volume":"227","author":"Y Jia","year":"2022","unstructured":"Jia Y, Shen K, Yang Y, Cai W, Wang K, Zhang Y, Zhao M, Luo L, Su L, Guan H et al (2022) Deacetylation of IRF8 inhibits iNOS expression and inflammation via SIRT1 in macrophages. Immunobiology 227(6):152300","journal-title":"Immunobiology"},{"key":"410_CR46","doi-asserted-by":"publisher","first-page":"104468","DOI":"10.1016\/j.cellimm.2021.104468","volume":"371","author":"KS Chauhan","year":"2022","unstructured":"Chauhan KS, Das A, Jaiswal H, Saha I, Kaushik M, Patel VK, Tailor P (2022) IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression. Cell Immunol 371:104468","journal-title":"Cell Immunol"},{"key":"410_CR47","doi-asserted-by":"crossref","unstructured":"Peng CD, Wang L, Jiang DM, et al. Establishing and validating a spotted tongue recognition and extraction model based on multiscale convolutional neural network. Digit Chin Med. 2022;5(1):49\u201358.","DOI":"10.1016\/j.dcmed.2022.03.005"},{"issue":"2","key":"410_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/ajcp\/aqac044","volume":"158","author":"DC McQuaid","year":"2022","unstructured":"McQuaid DC, Katz SG, Xu ML (2022) IRF8 as a novel marker to differentiate between CD30-positive large cell lymphomas. Am J Clin Pathol 158(2):173\u2013176","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"410_CR49","doi-asserted-by":"publisher","first-page":"e17527","DOI":"10.1016\/j.heliyon.2023.e17527","volume":"9","author":"Z Zuo","year":"2023","unstructured":"Zuo Z, Kania AK, Patterson DG, Hicks SL, Maurer J, Gupta M, Boss JM, Scharer CD (2023) CRISPR\/Cas9 editing reveals IRF8 regulated gene signatures restraining plasmablast differentiation. Heliyon 9(6):e17527","journal-title":"Heliyon"},{"key":"410_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2022.01.004","volume":"122","author":"DC McQuaid","year":"2022","unstructured":"McQuaid DC, Panse G, Wang WL, Pinkus GS, Katz SG, Xu ML (2022) Global assessment of IRF8 as a novel cancer biomarker. Hum Pathol 122:1\u201310","journal-title":"Hum Pathol"},{"issue":"2","key":"410_CR51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/mrm.27064","volume":"80","author":"U Flogel","year":"2018","unstructured":"Flogel U, Schluter A, Jacoby C, Temme S, Banga JP, Eckstein A et al (2018) Multimodal assessment of orbital immune cell infiltration and tissue remodeling during development of graves disease by (1) H(19) F MRI. Magn Reson Med 80(2):711\u2013718. https:\/\/doi.org\/10.1002\/mrm.27064","journal-title":"Magn Reson Med"},{"issue":"2","key":"410_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/09273948.2019.1581227","volume":"28","author":"X Ding","year":"2020","unstructured":"Ding X, Cao Y, Xing Y, Ge S, Lin M, Li J (2020) TIMP-1 mediates inflammatory and immune response to IL-6 in adult orbital xanthogranulomatous disease. Ocul Immunol Inflamm 28(2):288\u2013297. https:\/\/doi.org\/10.1080\/09273948.2019.1581227","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"410_CR53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/IOP.0000000000001161","volume":"35","author":"O Sagiv","year":"2019","unstructured":"Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M et al (2019) Extraocular muscle enlargement and thyroid eye disease-like orbital inflammation associated with immune checkpoint inhibitor therapy in cancer patients. Ophthalmic Plast Reconstr Surg 35(1):50\u201352. https:\/\/doi.org\/10.1097\/IOP.0000000000001161","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"410_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/IOP.0b013e318238ecf7","volume":"28","author":"JD Pemberton","year":"2012","unstructured":"Pemberton JD, Fay A (2012) Idiopathic sclerosing orbital inflammation: a review of demographics, clinical presentation, imaging, pathology, treatment, and outcome. Ophthalmic Plast Reconstr Surg 28(1):79\u201383","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"410_CR55","doi-asserted-by":"publisher","first-page":"982130","DOI":"10.3389\/fphar.2022.982130","volume":"13","author":"Y Su","year":"2022","unstructured":"Su Y, Ding J, Yang F, He C, Xu Y, Zhu X et al (2022) The regulatory role of PDE4B in the progression of inflammatory function study. Front Pharmacol 13:982130. https:\/\/doi.org\/10.3389\/fphar.2022.982130","journal-title":"Front Pharmacol"},{"issue":"3","key":"410_CR56","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3892\/mmr.2019.9802","volume":"19","author":"XY Zheng","year":"2019","unstructured":"Zheng XY, Chen JC, Xie QM, Chen JQ, Tang HF (2019) Anti-inflammatory effect of ciclamilast in an allergic model involving the expression of PDE4B. Mol Med Rep 19(3):1728\u20131738. https:\/\/doi.org\/10.3892\/mmr.2019.9802","journal-title":"Mol Med Rep"},{"issue":"1","key":"410_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40246-022-00412-0","volume":"16","author":"J Hu","year":"2022","unstructured":"Hu J, Zhou S, Guo W (2022) Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis. Hum Genomics 16(1):38. https:\/\/doi.org\/10.1186\/s40246-022-00412-0","journal-title":"Hum Genomics"},{"key":"410_CR58","doi-asserted-by":"publisher","first-page":"858972","DOI":"10.3389\/fimmu.2022.858972","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Zhou Q (2022) Gene biomarkers related to th17 cells in macular edema of diabetic retinopathy: Cutting-Edge comprehensive bioinformatics analysis and in vivo validation. Front Immunol 13:858972. https:\/\/doi.org\/10.3389\/fimmu.2022.858972","journal-title":"Front Immunol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-024-00410-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-024-00410-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-024-00410-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T12:01:58Z","timestamp":1718884918000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-024-00410-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1186\/s12348-024-00410-4","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"9 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is not a clinical trial, hence the ethics approval and consent to participation are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participation"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}